Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Members of the CEACAM subfamily, including CEACAM5, belong to the CEA gene family. Additionally we are shipping CEACAM5 Kits (10) and CEACAM5 Proteins (10) and many more products for this protein.
Showing 10 out of 465 products:
Human Monoclonal CEACAM5 Primary Antibody for cELISA, FACS - ABIN108727
Baczy?ska, Wietrzyk, Madej, Krop-Watorek, Dabrowska, Widerak, Opolski, Ugorski: The tumorigenic potential of human CX-1 colon adenocarcinoma cells depends on carcinoembryonic antigen (CEACAM5) expression. in Cellular & molecular biology letters 2003
Show all 14 references for 108727
Human Monoclonal CEACAM5 Primary Antibody for ELISA, IF (p) - ABIN722946
Yu, Zhan, Liu, Lv, Duan: Plasma-enhanced antibody immobilization for the development of a capillary-based carcinoembryonic antigen immunosensor using laser-induced fluorescence spectroscopy. in Analytical chemistry 2013
Show all 8 references for 722946
Human Monoclonal CEACAM5 Primary Antibody for IHC (p), WB - ABIN1106531
GOLD, FREEDMAN: DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES. in The Journal of experimental medicine 1970
Show all 2 references for 1106531
Human Polyclonal CEACAM5 Primary Antibody for IHC (fro), IHC (p) - ABIN115285
Nap, Keuning, Burtin, Oosterhuis, Fleuren: CEA and NCA in benign and malignant breast tumors. in American journal of clinical pathology 1984
Show all 2 references for 115285
Human Monoclonal CEACAM5 Primary Antibody for FACS - ABIN319988
Price: Epitopes of carcinoembryonic antigen (CEA) defined by monoclonal antibodies. in British journal of cancer 1988
Show all 2 references for 319988
Human Polyclonal CEACAM5 Primary Antibody for EIA, WB - ABIN452835
Lagoudianakis, Kataki, Manouras, Memos, Papadima, Derventzi, Zografos, Papadopoulos, Katergiannakis, Konstadoulakis: Detection of epithelial cells by RT-PCR targeting CEA, CK20, and TEM-8 in colorectal carcinoma patients using OncoQuick density gradient centrifugation system. in The Journal of surgical research 2009
Show all 2 references for 452835
Human Polyclonal CEACAM5 Primary Antibody for FACS, IHC (p) - ABIN391544
Gambichler, Grothe, Rotterdam, Altmeyer, Kreuter: Protein expression of carcinoembryonic antigen cell adhesion molecules in benign and malignant melanocytic skin lesions. in American journal of clinical pathology 2009
Combination of the two tumor markers, CEA and CYFRA21-1, is a predictive and prognostic marker of docetaxel monotherapy for previously treated NSCLC patients
Patients with CEA-High stage I NSCLC have a higher risk of regional or systemic relapse and should be followed-up carefully.
Postoperative CEA level >2.5 ng/ml is a predictor of distant metastasis and a negative prognostic factor for survival in rectal cancer patients who receive preoperative chemoradiotherapy and curative surgery.
Data show that triple-negative breast cancer (TNBC) patients with pre-therapeutic serum high levels of both carcinoembryonic antigen (CEA) and cancer antigen 15-3 (CA15-3) had shorter overall survival (OS) and disease-free survival (DFS (show FST Antibodies)) rates than those in the low-level groups.
Serum CEA level is not influenced by the presence of benign dominant biliary stricture or superimposed bacterial cholangitis in patients with primary sclerosing cholangitis.
Preoperative-CEA was elevated (>/=5.0 ng/mL) in 73.6% of the colorectal cancer patients and remained elevated after surgery in 32.7% of the patients. Elevated postoperative-CA 19-9 (>/=50 U/mL) was observed in 9.5% of the patients. Neither elevated pre-CEA nor elevated pre-CA 19-9 was associated with relapse-free survival (RFS) but both elevated post-CEA and elevated post-CA 19-9 were associated with reduced RFS.
the diagnostic sensitivity and specificity of serum reactive oxygen species modulator 1 (show ROMO1 Antibodies) were only 41.38% and 86.21%, respectively, with the cutoff value of 27.22 ng/mL. The sensitivity and specificity of pleural fluid carcinoembryonic antigen were 69.23% and 88.00%, respectively, at the cutoff value of 3.05 ng/mL, while serum carcinoembryonic antigen were 80.77% and 72.00% at the cutoff value of 2.60 ng/mL.
we demonstrate that the incorporation of a 2A self-processing peptide derived from foot-and-mouth disease virus conveying co-translational cleavage into a two-chain anti-CD3 (show CD3 Antibodies) x anti-CEA diabody gene enables near-equimolar expression of diabody chains 1 and 2, and thus increases the final amount of assembled diabody.
Taken together, the results of our study identified CEACAM5 as a novel cell surface binding target of Middle East respiratory syndrome coronavirus that facilitates infection by augmenting the attachment of the virus to the host cell surface.
Data show that carcinoembryonic antigen (CEA) modestly differentiated between mucinous and nonmucinous lesions, and amylase (show AMY Antibodies) did not distinguish intraductal papillary mucinous neoplasms (IPMNs) from mucinous cystadenomas (MCAs).
a new mechanistic insight into how the CEA (show CEA Antibodies) IgV-like N domain participates in cellular events that can have a macroscopic impact in terms of cancer progression and metastasis.
Members of the CEACAM subfamily, including CEACAM5, belong to the CEA gene family. For general information on the CEA gene family, see CEACAM1 (MIM 109770).
carcinoembryonic antigen-related cell adhesion molecule 5
, carcinoembryonic antigen
, carcinoembryonic antigen-related cell adhesion molecule 5-like
, CEA-related cell adhesion molecule 20
, meconium antigen 100
, pregnancy-specific glycoprotein 30